AKBA · Akebia Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Akebia Therapeutics Inc Is A Fully Integrated Biopharmaceutical Company. The Company'S Operating Segment Is The Business Of Developing And Commercializing Novel Therapeutics. The Current Portfolio Of The Company Includes Auryxia (Ferric Citrate), A Medicine Approved And Marketed In The United States For The Control Of Serum Phosphorus Levels In Adult Patients With Dialysis-Dependent Chronic Kidney Disease And The Treatment Of Iron Deficiency Anemia, In Adult Patients With Non-Dialysis-Dependent Chronic Kidney Disease, Vafseo (Vadadustat), An Oral Hypoxia-Inducible Factor Prolyl Hydroxylase, Inhibitor Approved In Japan For The Treatment Of Anemia Due To Chronic Kidney Disease, And Hif-Ph Inhibitors In Preclinical Development.

HealthcareNasdaqUS

FLOAT

264.6M

FREE FLOAT %

96%

SHARES O/S

277.1M

MARKET CAP

$157.1M

EXCHANGE

Nasdaq

COUNTRY

AKBA Catalyst History

No catalysts recorded for AKBA yet

Day Trader Sniper hasn't classified a publishable catalyst for AKBA yet. New events appear here as they're scored.

Be early on the next AKBA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

AKBA · Akebia Therapeutics, Inc.

AKBA Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.